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Abstract 
Background: In randomised controlled trials, procalcitonin (PCT)-guided antibiotic treatment has been proven to 
significantly reduce length of antibiotic therapy in intensive care unit (ICU) patients. However, concern was raised on 
low protocol adherence and high rates of overruling, and thus the value of PCT-guided treatment in real clinical life 
outside study conditions remains unclear. In this study, adherence to a PCT protocol to guide antibiotic treatment in 
patients with severe sepsis and septic shock was analysed.
Methods: From 2012 to 2014, surgical ICU patients with severe sepsis or septic shock were retrospectively screened 
for PCT measurement series appropriate to make treatment decisions on antibiotic therapy. We compared (1) patients 
with appropriate PCT measurement series to patients without appropriate series; (2) patients who reached the antibi-
otic stopping advice threshold (PCT < 0.5 ng/mL and/or decrease to 10% of peak level) to patients who did not reach 
a stopping advice threshold; and (3) patients who were treated adherently to the PCT protocol to non-adherently 
treated patients. The groups were compared in terms of antibiotic treatment duration, PCT kinetics, and other clinical 
outcomes.
Results: Of 81 patients with severe sepsis or septic shock, 14 were excluded due to treatment restriction or short 
course in the ICU. The final analysis was performed on 67 patients. Forty-two patients (62.7%) had appropriate PCT 
measurement series. In patients with appropriate PCT series, median initial PCT (p = 0.001) and peak PCT levels 
(p < 0.001) were significantly higher compared to those with non-appropriate series. In 26 patients with appropriate 
series, PCT levels reached an antibiotic stopping advice. In 8 of 26 patients with stopping advice, antibiotics were 
discontinued adherently to the PCT protocol (30.8%). Patients with adherently discontinued antibiotics had a shorter 
antibiotic treatment (7d [IQR 6–9] vs. 12d [IQR 9–16]; p = 0.002). No differences were seen in terms of other clinical 
outcomes.
Conclusion: In patients with severe sepsis and septic shock, procalcitonin testing was irregular and adherence to a 
local PCT protocol was low in real clinical life. However, adherently treated patients had a shorter duration of antibi-
otic treatment without negative clinical outcomes. Procalcitonin peak values and kinetics had a clear impact on the 
regularity of PCT testing.
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Background
Length of antibiotic therapy in critically ill patients 
can be safely guided by PCT-guided protocols. A 
recent large study and several reviews and meta-anal-
yses demonstrated that implementation of PCT-guided 
protocols leads to a significant reduction in antibiotic 
exposure of 2–3.5 days [1–8]. Despite this reduction, a 
recent Cochrane Database review found no beneficial 
effects on mortality, duration of mechanical ventilation, 
or reinfection [9]. However, the use of PCT to guide 
treatment decisions is recommended in current guide-
lines [10, 11].
Concern was raised on low protocol adherence in pro-
spective trials. The low rate of compliance of PCT-guided 
algorithms and the high rate of exclusion weaken the real 
impact of such protocols in the clinical decision-making 
process [12]. However, own data revealed that in clini-
cal routine, duration of antibiotic therapy in septic ICU 
patients decreased after implementation of a PCT proto-
col [13], and combination with an antibiotic stewardship 
programme had positive impact on antibiotic use density 
and the spectrum of antibiotic classes used in the ICU 
[14]. Nonetheless, data are scarce regarding adherence 
to PCT protocols for guidance of antibiotic treatment. A 
retrospective analysis from seven German intensive care 
units (ICU) showed that the use of PCT measurement 
to monitor sepsis treatment is not well established in 
clinical routine [15]. The aim of this retrospective cohort 
study from a surgical ICU was to analyse adherence to 
a PCT-guided antibiotic treatment protocol in patients 
with severe sepsis and septic shock. Furthermore, we 
sought to assess factors affecting protocol adherence, to 
get a better understanding on the use of PCT in real clin-
ical life.
Methods
In brief, patients with severe sepsis and septic shock were 
retrospectively identified by a database query from the 
hospital information system by their primary diagnosis 
(i.e. severe sepsis/septic shock). In septic patients, pro-
calcitonin measurement series were analysed to assess 
whether measurement series were appropriate to guide 
antibiotic treatment or not. Patients with appropriate 
PCT measurement series were compared to patients 
without appropriate series in terms of antibiotic treat-
ment duration, PCT kinetics, and other clinical out-
comes. Afterwards, among patients with appropriate 
PCT measurement series, those with PCT stopping 
advice (PCT < 0.5 ng/mL and/or decrease to 10% of peak 
level) to discontinue antibiotics according to the local 
PCT protocol were compared to patients which did not 
reach a stop threshold.
If antibiotics were discontinued when a PCT stopping 
advice was reached, patients were classified as being 
treated adherently to the PCT protocol. Finally, adher-
ently treated patients were compared to non-adherently 
treated patients again in terms of duration of antibiotic 
treatment, PCT kinetics, and other clinical outcomes.
Study design and patients
In this retrospective cohort study, patients admitted to 
the surgical intensive care unit (ICU) between 2012 and 
2014 with the diagnosis of severe sepsis or septic shock 
were included. To define the first episode of sepsis, the 
time of sepsis diagnosis and the source of infection, data 
were taken from a review of patient records by four of the 
authors. Furthermore, data on antibiotic treatment were 
analysed in the same way. Information on the following 
variables was available from the hospital information sys-
tem and the patients’ chart:
  • Age, gender and Simplified Acute Physiology Score 
(SAPS) II at admission to ICU.
  • Maximum sequential organ failure score (SOFA).
  • Type of infection.
  • Length of stay in ICU and length of stay in hospital.
  • PCT measurements and results during ICU stay.
  • Duration of mechanical ventilation.
  • Doses of antibiotics and antibiotic use density during 
ICU stay.
  • ICU survival status.
  • Final diagnosis at discharge.
Description of the local PCT protocol and PCT stopping 
advice
Procalcitonin-guided antibiotic treatment was intro-
duced in our ICU in 2011 [14]. The PCT protocol used 
from 2012 contains the following rules:
  • Initiation of antibiotic therapy based on clinical deci-
sion.
  • Daily PCT (day 1–3) measurement in patients under-
going antibiotic treatment started on admission to 
ICU or clinical diagnosis of sepsis, severe sepsis or 
septic shock.
  • From day 4 on, PCT samples every other day in 
patients under antibiotic treatment.
Antibiotic stopping advice: If PCT is < 0.50  ng/mL or 
PCT decreases to ≤ 10% from peak level, discontinu-
ation of antibiotic treatment is recommended. If PCT 
is ≥ 0.5  ng/mL and does not decrease to ≤ 10% of peak 
level, or even increases, discontinuation of antibiotics 
is only suggested assuming other conditions (unrelated 
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to bacterial infections) leading to increased PCT levels 
(Additional file 1: Figure S1).
Definition of appropriate PCT measurement series
The local PCT protocol recommended daily PCT meas-
urements in patients under antibiotic treatment on day 
1–3, and PCT measurements every other day from day 4 
on. However, since it is not mandatory to have daily PCT 
measurements, to guide antibiotic treatment sufficiently, 
we decided that it was appropriate if PCT results were 
available at regular intervals (e.g. on day 2, 3, or 4, and 
then on 5, 6, 7, or 8 etc.).
A selection of patients with appropriate PCT meas-
urement series was then done accordingly to a recently 
published analysis [15] (Fig. 1). Patients with restriction 
of critical care treatment, or short stay (≤ 1–2 days) in 
the ICU, were removed from the analysis beforehand. 
Antibiotic therapy and PCT measurements were evalu-
ated only for the first antibiotic episode of infection.
Definition of adherence to the PCT protocol
According to the implemented PCT algorithm, patients 
with appropriate PCT measurement series were consid-
ered to have been treated adherently if antibiotics were 
discontinued within 24 h after a PCT decrease to ≤ 10% 
from peak level or a PCT value declining to < 0.5  ng/
mL. The PCT decrease was calculated by the following 
formula:




PCT before day i
)
− PCT at day i
max
(
PCT before day i
)
Fig. 1 Selection algorithm to identify patients with appropriate procalcitonin (PCT) measurement series according to [15]
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The PCT value at day i was compared to all available 
PCT values at the days before.
Group comparisons and statistical analysis
Comparisons regarding antibiotic treatment duration, 
PCT kinetics, and other clinical outcomes were per-
formed for three different groups of patients:
1. Patients with appropriate PCT measurement series 
versus patients without appropriate PCT measure-
ment series.
2. Patients who reached antibiotic stopping advice ver-
sus patients who did not reach antibiotic stopping 
advice according to the local PCT protocol.
3. For patients who reached antibiotic stopping advice: 
Patients treated adherently to the PCT protocol ver-
sus patients treated non-adherently (i.e. antibiotics 
stopped vs. not stopped when PCT stopping advice 
occurred).
Variables were analysed by
  • Counts and proportions for categorical variables,
  • means and standard deviations and medians and 
quartiles for numerical variables.
95% confidence intervals for proportions were deter-
mined with the exact method of Clopper and Pearson. 
Pearson’s χ2 test was applied for group comparisons of 
binary variables. The Wilcoxon rank-sum test was applied 
for comparing two groups, and p values are reported. 
Differences with p < 0.05 were considered statistically 
significant. All statistical analyses were performed with 
R version 3.1.2 (R Foundation for Statistical Computing, 
Vienna, Austria).
Results
Between 2012 and 2014, 81 patients with the final diag-
nosis of severe sepsis and septic shock were identified 
from the hospital information system. Of these, 14 were 
excluded due to treatment restriction or short stay in 
the ICU (Fig. 2). The final analysis was performed for 67 
patients. According to our definition (Fig. 1), 25 patients 
(37.3%) did not have appropriate PCT measurement 
series. Of the remaining 42 patients, 26 patients reached 
an antibiotic stopping advice threshold according to the 
local PCT protocol. In 8 cases (30.8%) antibiotics were 
stopped adherently to the PCT protocol.
Factors affecting appropriate versus non‑appropriate PCT 
measurement series
Table  1 shows the patient characteristics and outcomes 
of patients with appropriate PCT measurement series 
(n = 42) compared to those with non-appropriate PCT 
measurement series (n = 25). Patients with appropri-
ate PCT measurement series had statistically significant 
longer ventilation times and a longer duration of anti-
biotic treatment in the first episode of sepsis. ICU mor-
tality was lower in the group with non-appropriate PCT 
series, and the rate of pneumonias was higher in the non-
appropriate group.
Median initial and peak PCT values of the first septic 
episode were statistically significant higher in the group 
of patients with appropriate PCT measurement series.
Factors affecting achievement of PCT stopping advice 
threshold
Table  2 gives the patient characteristics and outcomes 
of patients who reached an antibiotic stopping advice 
threshold according to the PCT protocol (n = 26) com-
pared to those without reaching the stopping advice 
threshold (n = 16).
Patients who reached the antibiotic stopping advice 
had a statistically significant longer stay in the hospital 
and a relevant lower ICU mortality. SAPS II and maxi-
mum SOFA scores were higher in patients who did not 
reach the stopping advice. Median initial and peak PCT 
values were higher in patients with stopping advice, but 
these differences were not statistically significant. Length 
of antibiotic therapy was comparable in both groups. In 
24 of 26 cases, patients reached the stopping advice by a 
90% decrease in PCT. A 90% decrease plus PCT < 0.5 ng/
mL occurred only in 2 of 26 patients. A drop of PCT 
below < 0.5 ng/mL alone was in none of the cases a rea-
son for a stopping advice. In patients who did not reach 
a stopping advice in the PCT protocol, a secondary PCT 
increase occurred in 81.3% and only in 42.3% of patients 
who reached the stopping advice threshold.
Factors affecting adherence to the PCT protocol
Table  3 shows the patient characteristics and outcomes 
of patients treated adherently to the antibiotic stopping 
advice (n = 8) compared to those with non-adherent 
treatment (n = 18).
Both groups were comparable with respect to SAPS 
II, maximum SOFA scores, length of hospital and ICU 
stay, and ventilation hours. The rate of male patients was 
lower in the adherent group, and median length of anti-
biotic treatment was statistically significant shorter (7 vs. 
12 days).
In the adherently treated group, 88% per cent had 
abdominal sepsis. A trend was seen towards a lower 
ICU mortality and higher median initial PCT values in 
adherently treated patients. In 75% of adherently treated 
patients, the initial PCT value and peak value were 
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concordant, whereas in non-adherent patients only in 
44% the initial and peak values of PCT were concordant.
Discussion
Factors affecting adherence to the PCT protocol
Currently, there are only limited data on PCT protocol 
adherence in critically ill patients outside of study con-
ditions. One study in medical ICU patients revealed 
an adherence below 50% to a local PCT protocol [16]. 
However, this study did not compare adherently treated 
patients to non-adherently treated patients. Thus, our 
study reveals important insights on whether and how 
the promising strategy of PCT-guidance is transferred to 
clinical routine practice.
We detected a low adherence to discontinue antibiotics 
adherently to a PCT stopping advice in clinical real life. 
In only 8 out of 81 patients with severe sepsis and sep-
tic shock during the entire study period, or in 67 patients 
who entered the final statistical analysis, the algorithm 
was fully applied. However, in patients with a low PCT 
(< 0.5 ng/mL) or a marked decrease of PCT levels (≤ 10% 
of peak level), a shorter antibiotic treatment was not 
associated with worse clinical outcomes. Thus, our study 
confirms the results of a recent large study [1] and several 
reviews and meta-analyses [2–6]. Procalcitonin is able to 
support clinical decision-making to discontinue antibiot-
ics when PCT decrease goes along with clinical improve-
ment. However, in our study, antibiotics were continued 
in nearly 70% of patients although antibiotic discontinu-
ation was recommended by the PCT protocol. Algo-
rithm overruling was also of concern in prospective trials 
where overruling rates reached from 16 to 53% [17–19]. 
Fig. 2 Flow diagram of septic ICU patients and distribution to different subgroups of procalcitonin testing and protocol adherence. pt(s) patient(s)
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Expectably, overruling rates were higher in real life since 
the PCT protocol was not applied under controlled 
study conditions and populations are not comparable 
due to strict in- and exclusion criteria in randomised 
trials. Exclusion rates in randomised PCT studies range 
from 0.3% [20] to 84% [21], thus not necessarily reflect-
ing clinical real life. For example, patients with common 
ICU infections, e.g. caused by Pseudomonas aeruginosa 
and Acinetobacter baumannii, which were excluded in 
several studies [17–19] were not excluded in our study. 
Furthermore, probably we cannot exclude that inappro-
priate septic source control contributed to low adherence 
to antibiotic stopping advices in our study, and we did 
not analyse the impact of multi drug resistant pathogens 
on antibiotic treatment duration.
Nonetheless, the low rate of less than 10% of sep-
tic patients in which discontinuation of antibiotics was 
accompanied by a PCT stop signal challenges the clini-
cal relevance of PCT-guided antibiotic stewardship and 
efforts should be made to improve adherence to PCT 
protocols in clinical practice.
Kinetics of procalcitonin also affect adherence to dis-
continue antibiotics when a stopping advice thresh-
old is reached. Median initial PCT levels were higher 
in adherently treated patients. In 75% of the adherently 
treated patients, the initial PCT corresponded to the 
peak value. Contrasting to that, in 56% of the not adher-
ently treated patients the PCT value rises after the initial 
value. For clinicians, high initial PCT levels seem to be 
no barrier to stop antibiotics according to the PCT pro-
tocol, but secondarily increasing PCT seems to prompt 
clinicians to continue antibiotics. Similarly, to the study 
by Jensen [20], in clinical real life, secondary increases 
seem to be interpreted as “alert PCT”. For most patients, 
a decline of PCT to ≤ 10% of peak value was a trigger for 
an antibiotic stopping advice and not the absolute limit of 
PCT < 0.5 ng/mL. Thus, in patients with severe sepsis and 
septic shock, relative variations of PCT seem to be more 
important to the clinician than absolute values. Further-
more, in patients with secondary PCT increases, the pro-
calcitonin protocol was more frequently overruled and 
antibiotic treatment continued despite reaching a stop-
ping advice.
Our data suggest that certain types of infection like 
pneumonia or abdominal sepsis might affect adherence 
to PCT protocols as well. In patients who reached a stop-
ping advice, those with abdominal sepsis were treated 
adherently in 43% cases (7/15), whereas patients with 
Table 1 Demographics and  clinical data of  patients with  appropriate and  non-appropriate procalcitonin (PCT) 
measurement series
Patients with appropriate PCT 
series (n = 42)
Patients with non‑appropriate PCT 
series (n = 25)
p value
Age, years (median [IQR]) 68 [59–76] 76 [68–79] 0.172
SAPS II score (median [IQR]) 40 [29–51] 38 [32–47] 0.807
Male gender (% [95% CI]) 59.5 [43.3–74.4] 60.0 [38.7–78.9] 0.999
ICU mortality (% [95% CI]) 40.5 [26–57] 32.0 [14.9–53.5] 0.604
Ventilation hours (median [IQR]) 423 [68–840] 102 [8–335] 0.012
ICU LOS, days (median [IQR]) 17 [5–41] 11 [4–21] 0.264
Hospital LOS, days (median [IQR]) 42 [25–73] 39 [25–54] 0.351
SOFA score max (median [IQR]) 11 [9–13] 9 [8–11] 0.112
Length of antibiotic treatment, days (median [IQR]) 10 [7–13] 5 [4–6] < 0.001
Antibiotic use density, DDD (median [IQR]) 11 [9–23] 6 [4–9] < 0.001
Initial PCT value, ng/mL (median [IQR]) 9.15 [3.1–32.4] 1.55 [0.9–4.6] 0.001
Peak PCT value, ng/mL (median [IQR]) 30.2 [7.1–60.7] 3.8 [1.6–10.3] < 0.001
% [95% CI] (n) % [95% CI] (n)
Cause of infection
Abdominal sepsis 52.4 [36.4–67.9] (22) 44.0 [24.4–65.1] (11)
Bloodstream infection 0 4.0 [0.1–20.3] (1)
Pleural empyema 9.5 [2.6–22.6] (4) 0
Pneumonia 19.0 [8.6–34.1] (8) 32.0 [14.9–53.5] (8)
Prosthetic infection 0 8.0 [1.0–26.0] (2)
Urogenital sepsis 9.5 [2.6–22.6] (4) 8.0 [1.0–26.0] (2)
Soft tissue infection 2.4 [0.6–12.6] (1) 4.0 [0.1–20.3] (1)
Unknown 7.1 [1–19] (3) 0
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pneumonia were treated adherently only in 14% (1/7). 
However, due to the small number of patients with other 
infection sites than abdomen or lung, this could not be 
proven statistically in this study. Nonetheless, these 
results are interesting since mortality in critically ill sep-
tic patients with pneumonia or abdominal sepsis are 
comparable [22, 23].
Factors affecting appropriate versus non‑appropriate PCT 
measurement series
A prerequisite to PCT-guided antibiotic stewardship is 
regular measurements. In our study, 62.7% had appropri-
ate PCT measurement series. Median initial PCT values 
and peak values were statistically significantly higher in 
the group with appropriate measurement series. These 
results suggest that frequency of PCT testing is affected 
by PCT levels, and high PCT values might prompt cli-
nicians to request PCT testing more frequently. In the 
group of patients with non-appropriate PCT series, there 
was a higher number of patients with pneumonia. It is 
well known that peak values of PCT are lower in res-
piratory tract infections compared to other kind of infec-
tions [24–26]. Lower duration of mechanical ventilation, 
shorter stay in the ICU, and lower mortality rates reflect 
that patients without appropriate PCT measurement 
series were in a better clinical condition, and probably 
regularly PCT testing was not considered necessary by 
the clinician. In patients with inappropriate PCT series, 
median duration of antibiotic treatment was 5 days, and 
thus more regular PCT testing likely would not have 
had beneficial impact on further reduction in antibiotic 
exposure.
Factors affecting achievement of PCT stopping advice 
threshold
Beside its value for biomarker-guided antibiotic steward-
ship, PCT can be used as a prognostic value. Patients who 
did not reach the PCT stopping advice threshold had 
higher mortality rates (63%) compared to those where 
PCT declined indicating that the infection is under con-
trol (27%). Median initial PCT levels and peak levels were 
higher in patients with stopping advice. However, these 
results were statistically not significant. Interestingly, in 
81.3% (13/16) of patients without reaching the PCT stop-
ping advice, PCT levels increased after the initial value. 
In patients with stopping advice, this occurred only in 
42.3% (11/26). These results are in line with previous 
studies which showed that high PCT levels are associated 
Table 2 Demographics and clinical data of patients with and without procalcitonin (PCT) stopping advice
Patients with PCT stopping 
advice (n = 26)
Patients without PCT stopping 
advice (n = 16)
p value
Age, years (median [IQR]) 68 [59–75] 70 [62–79] 0.475
SAPS II score (median [IQR]) 40 [29–51] 44 [33–52] 0.597
Male gender (% [95% CI]) 69.2 [48.2–85.7] 43.8 [19.8–70.1] 0.121
ICU mortality (% [95% CI]) 26.9 [11.6–47.8] 62.5 [35.4–84.8] 0.029
Ventilation hours (median [IQR]) 597 [96–1260] 238 [47–461] 0.068
ICU LOS, days (median [IQR]) 23 [5–56] 11 [5–20] 0.212
Hospital LOS, days (median [IQR]) 56 [35–100] 23 [17–44] 0.002
SOFA score max (median [IQR]) 11 [9–12] 13 [9–15] 0.320
Length of antibiotic treatment, days (median [IQR]) 10 [8–13] 10 [7–12] 0.398
Antibiotic use density, DDD (median [IQR]) 13 [10–24] 10 [8–15] 0.136
Initial PCT value, ng/mL (median [IQR]) 20.0 [3.3–42.7] 5.1 [2.8–10.8] 0.136
Peak PCT value, ng/mL (median [IQR]) 40.5 [9.2–69.7] 16.2 [6.0–32.5] 0.095
% [95% CI] (n) % [95% CI] (n)
Cause of infection
Abdominal sepsis 57.7 [36.9,76.6] (15) 43.8 [19.8–70.1] (7)
Bloodstream infection 0 0
Pleural empyema 11.5 [2.4–30.2] (3) 6.3 [0.2–30.2] (1)
Pneumonia 26.9 [11.5–47.8] (7) 6.3 [0.2–30.2] (1)
Prosthetic infection 0 0
Urogenital sepsis 3.8 [0.1–19.6] (1) 18.8 [4.0–45.6] (3)
Soft tissue infection 0 6.3 [0.2–30.2] (1)
Unknown 0 18.8 [4.0–45.6] (3)
Page 8 of 10Hohn et al. Ann. Intensive Care  (2018) 8:68 
with an unfavourable outcome [27, 28]. Furthermore, a 
not adequately declining PCT is an independent predic-
tor of mortality in septic patients [29, 30]. In our study, 
the shorter ICU and hospital lengths of stay in patients 
without stopping advice might be founded in the fact that 
those patients had a higher mortality.
Limitations
There are limitations of the present study which should 
be mentioned. Taken the overall low sample size together 
with the retrospective study design, all results and their 
interpretation should be taken with caution. As possibly 
not all septic cases might have been registered correctly 
in the hospital’s database, we cannot exclude a selec-
tion bias in our analysis. The selection of patients was 
also possibly affected by the definition of an appropriate 
measurement series. However, today, there is no universal 
definition how often and in what intervals PCT should be 
measured to be sufficient to guide antibiotic treatment. 
In addition, there are little data for the frequency of PCT 
testing and adherence to PCT protocols in clinical real 
life. In our study, we used a recently published definition 
to classify a series of PCT measurements as appropriate 
to guide antibiotic treatment [15]. Furthermore, we can 
only assess correlation and cannot comment on causality, 
and thus, probably additional factors may have contrib-
uted to the results.
Furthermore, we can only comment on the first episode 
of sepsis and did not analyse the impact of PCT guidance 
on further septic episodes during the stay in ICU. As our 
data were collected retrospectively, diagnosis of sepsis 
was not yet according to the new sepsis definition [31], 
and thus we may have missed patients because one in 
eight patients admitted to intensive care units with infec-
tion and new organ failure does not meet the condition 
of at least two systemic inflammatory response syndrome 
criteria.
Conclusion
Our study showed that a PCT protocol works outside 
clinical studies, but these benefits along with interna-
tional guideline recommendations have not yet entered 
the daily routine in intensive care medicine. In patients 
with severe sepsis and septic shock, PCT testing was 
irregular and adherence to a PCT protocol for discon-
tinuation of antibiotic treatment was low, but when 
applied it was associated with a considerably shorter 
Table 3 Demographics and  clinical data of  patients with  procalcitonin (PCT) stopping advice treated adherently 
and non-adherently to the PCT protocol
Patients adherent to PCT 
stopping advice (n = 8)
Patients non‑adherent to PCT 
stopping advice (n = 18)
p value
Age, years (median [IQR]) 67 [59–75] 68 [59–75] 0.560
SAPS II score (median [IQR]) 35 [31–43] 44 [28–51] 0.655
Male gender (% [95% CI]) 50.0 [15.7–84.3] 77.8 [30.6–69.4] 0.197
ICU mortality (% [95% CI]) 12.5 [0.3–52.7] 33.3 [13.3–59.0] 0.375
Ventilation hours (median [IQR]) 353 [68–621] 735 [209–1508] 0.317
ICU LOS, days (median [IQR]) 24 [3–38] 23 [12–59] 0.780
Hospital LOS, days (median [IQR]) 57 [47–79] 54 [34–100] 0.824
SOFA score max (median [IQR]) 11 [9–12] 12 [9–13] 0.557
Length of antibiotic treatment, days (median [IQR]) 7 [6–9] 12 [9–16] 0.002
Antibiotic use density, DDD (median [IQR]) 10 [7–12] 18 [12–26] 0.001
Initial PCT value, ng/mL (median [IQR]) 20.0 [9.4–38.2] 16.8 [2.0–42.7] 0.560
Peak PCT value, ng/mL (median [IQR]) 32.3 [9.4–64.2] 44.9 [13.9–69.7] 0.718
% [95% CI] (n) % [95% CI] (n)
Cause of infection
Abdominal sepsis 87.5 [47.3–99.7] (7) 44.4 [21.5–69.2] (8)
Bloodstream infection 0 0
Pleural empyema 0 16.7 [3.5–41.4] (3)
Pneumonia 12.5 [0.3–52.7] (1) 33.3 [13.3–59.0] (6)
Prosthetic infection 0 0
Urogenital sepsis 0 5.6 [0.1–27] (1)
Soft tissue infection 0 0
Unknown 0 0
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duration of antibiotic treatment and a lower antibiotic 
consumption for the first septic episode without nega-
tive clinical outcomes. Severity of illness, PCT peak 
levels, and PCT kinetics, respectively, might affect 
frequency of PCT testing and protocol adherence. 
Patients at high risk without sufficiently decreasing or 
even increasing PCT levels seem to prompt clinicians 
to continue antibiotics and to overrule PCT protocols 
despite reaching antibiotic stopping advice thresholds.
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